A detailed history of Steward Financial Group LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Steward Financial Group LLC holds 3 shares of LGND stock, worth $343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$343
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$58.86 - $72.67 $176 - $218
3 New
3 $0
Q1 2023

May 05, 2023

BUY
$65.67 - $77.08 $197 - $231
3 Added 100.0%
6 $0
Q4 2022

Feb 13, 2023

BUY
$61.72 - $96.74 $185 - $290
3 New
3 $0
Q2 2022

Jul 22, 2022

BUY
$74.52 - $117.06 $223 - $351
3 New
3 $0

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.94B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.